Haemonetics Corp.
HAE
Market Cap$3.21B
Close$
$169.08
148.6% upside
Current Fair Value
148.6% upsideUndervalued by 148.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.21 Billion |
|---|---|
| Enterprise Value | $4.11 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.32 |
| Beta | 0.41 |
| Outstanding Shares | 50,286,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 24.69 |
|---|---|
| PEG | 123.33 |
| Price to Sales | 2.52 |
| Price to Book Ratio | 3.78 |
| Enterprise Value to Revenue | 2.99 |
| Enterprise Value to EBIT | 19.93 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 1.35 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon